第一个仿制药独家制是否为早期进入专利链接体系中的仿制药提供经济激励?
1College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea.
Frontiers in public health
|August 21, 2023
概括
韩国的专利链接系统提供了第一个仿制药的独家性,鼓励早期进入市场. 尽管仿制药的普及延迟,但第一行动者获得了相当大的市场份额,证明了该系统的有效性.
科学领域:
- 制药政策和经济学 制药政策和经济学
- 药物使用研究 药物使用研究
- 医疗服务研究 医疗服务研究
背景情况:
- 韩国实施了一种专利链接系统,以激励早期的仿制药进入市场.
- 了解通用透动态和第一行动者的优势对于政策评估至关重要.
研究的目的:
- 在专利链接系统下分析韩国仿制药透曲线.
- 评估与后者相比,第一批通用药的市场份额优势.
主要方法:
- 已识别的原始人-仿制品对,具有第一个仿制品独家权 (2015-2020年).
- 将仿制药分类为第一行动者或迟到者.
- 分析了基于体积的月度处方来描述透曲线.
- 利用物流增长模型来估计和的市场份额.
主要成果:
- 分析了28种原始药-仿制药对;仿制药在33个月内达到30%的和市场份额.
- 透率因药物的国籍,途径和仿制药的数量而异.
- 迟到者减少了透速度和市场份额,而先进者始终表现出优势.
结论:
- 在韩国,通用药的采用往往是延迟的和特定于环境的.
- 首发者优势证实,独家期限可以有效地激励早期的仿制药进入专利链接系统.
更多相关视频
06:21An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
Published on: May 7, 2018
6.6K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.1K
相关概念视频
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Factors Influencing Drug Absorption: Presystemic Elimination
262
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
262
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
First Pass Effect
5.6K
Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
5.6K
Drug Elimination by Renal Route: Tubular Secretion
2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
